CV Sciences (CVSI) Accounts Payables (2010 - 2026)

CV Sciences has disclosed Accounts Payables across 17 years of filings, most recently posting $1.1 million for Q1 2026.

• Accounts Payables for Q1 2026 came in at $1.1 million, down 27.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (down 27.81% YoY), and the FY2025 annual result was $1.0 million, down 45.77% from the prior year.
• Accounts Payables came in at $1.1 million for Q1 2026 at CV Sciences, up from $1.0 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $2.7 million in Q1 2022 to a low of $1.0 million in Q4 2025.
• The 5-year median for Accounts Payables is $2.2 million (2022), against an average of $2.0 million.
• Across the five-year window, Accounts Payables surged 282.82% in 2022 and plunged 45.77% in 2025, its largest moves.
• CV Sciences' Accounts Payables stood at $2.3 million in 2022, then climbed by 1.09% to $2.3 million in 2023, then retreated by 16.63% to $1.9 million in 2024, then slumped by 45.77% to $1.0 million in 2025, then advanced by 3.45% to $1.1 million in 2026.
• The last three Accounts Payables figures came in at $1.1 million (Q1 2026), $1.0 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.